Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia.
Effect of Combined Supplementation With Long-chain ω-3 Polyunsaturated Fatty Acids, Vitamin D, and Calcium as a Potential Adjuvant in the Preservation of Bone Mass and Bone Turnover Biomarkers in Patients With Acute Lymphoblastic Leukemia.
Sponsor: Coordinación de Investigación en Salud, Mexico
A NA clinical study on Acute Lymphoblastic Leukemia and Vitamin d Deficiency, this trial is ongoing. The trial is conducted by Coordinación de Investigación en Salud, Mexico and has accumulated 4 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
4 versions recorded-
Aug 2025 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Aug 2023 — Jul 2024 [monthly]
Recruiting NA
First recorded
Sep 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Coordinación de Investigación en Salud, Mexico
- Instituto Mexicano del Seguro Social
For direct contact, visit the study record on ClinicalTrials.gov .